Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yehuda Handelsman

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Overcoming obstacles in risk factor management in type 2 diabetes mellitusYehuda Handelsman, Paul S Jellinger
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 21, 2015
SGLT-2 INHIBITION ADDED TO GLP-1 AGONIST THERAPY FOR TYPE 2 DIABETES: WHAT IS THE BENEFIT?Zachary T Bloomgarden, Yehuda Handelsman
Journal of the American Heart Association|June 24, 2018
PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A ReviewYehuda Handelsman, Norman E Lepor
Nature Clinical Practice. Endocrinology & Metabolism|June 5, 2008
Pharmacologic treatment options for prediabetesWilla A Hsueh, Yehuda Handelsman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 8, 2016
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDSYehuda Handelsman, Michael D Shapiro
Journal of Diabetes|October 7, 2010
Insulin treatment of Type 2 diabetes: a clinical perspectiveZachary Bloomgarden, Andrew Drexler, Yehuda Handelsman
Journal of Cardiac Failure|August 16, 2022
DCRM Multispecialty Recommendations in Patients With Heart FailureArsalan Hamid, Yehuda Handelsman, Javed Butler
Expert Review of Clinical Pharmacology|December 7, 2011
Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?Yehuda Handelsman, Vivian Fonseca, Julio Rosenstock
Current Diabetes Reports|April 29, 2010
Bile acid sequestrants for lipid and glucose controlBart Staels, Yehuda Handelsman, Vivian Fonseca
Journal of Diabetes|September 29, 2011
Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipidsZachary Bloomgarden, Yehuda Handelsman, Daniel Einhorn
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Overcoming obstacles in risk factor management in type 2 diabetes mellitusYehuda Handelsman, Paul S Jellinger
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 21, 2015
SGLT-2 INHIBITION ADDED TO GLP-1 AGONIST THERAPY FOR TYPE 2 DIABETES: WHAT IS THE BENEFIT?Zachary T Bloomgarden, Yehuda Handelsman
Journal of the American Heart Association|June 24, 2018
PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A ReviewYehuda Handelsman, Norman E Lepor
Nature Clinical Practice. Endocrinology & Metabolism|June 5, 2008
Pharmacologic treatment options for prediabetesWilla A Hsueh, Yehuda Handelsman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 8, 2016
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDSYehuda Handelsman, Michael D Shapiro
Journal of Diabetes|October 7, 2010
Insulin treatment of Type 2 diabetes: a clinical perspectiveZachary Bloomgarden, Andrew Drexler, Yehuda Handelsman
Journal of Cardiac Failure|August 16, 2022
DCRM Multispecialty Recommendations in Patients With Heart FailureArsalan Hamid, Yehuda Handelsman, Javed Butler
Expert Review of Clinical Pharmacology|December 7, 2011
Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?Yehuda Handelsman, Vivian Fonseca, Julio Rosenstock
Current Diabetes Reports|April 29, 2010
Bile acid sequestrants for lipid and glucose controlBart Staels, Yehuda Handelsman, Vivian Fonseca
Journal of Diabetes|September 29, 2011
Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipidsZachary Bloomgarden, Yehuda Handelsman, Daniel Einhorn
Pageof 16